Helus Pharma HELP
NASDAQ HELP
$10.77 +0.25 (+2.38%)
As of: Oct 28, 2026 · 2:33 PM EDT

Helus Pharma (HELP) Income from Continuing Operations (2020 - 2021)

Updated

Cybin (HELP) posted Income from Continuing Operations of -$20.28 million for FY2023 (year ended Feb 28, 2023).

Analysis

Helus Pharma (HELP) Income from Continuing Operations (2020 - 2021) Analysis & Trends

  • Business Quant data shows HELP's Income from Continuing Operations at -$63.6 million in FY2022 and -$23.07 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Citigroup 210.88 Bn 210.88 Bn - 5.42 Bn
2 Bhp 207.41 Bn 150.59 Bn - -
3 Bank Of Nova Scotia 116.92 Bn -315.52 Bn - 2.12 Bn
4 Nokia 49.31 Bn 49.31 Bn 2.58 Bn 481.22 Mn
5 Haleon 45.04 Bn 38.67 Bn - -
6 Gold Fields 31.78 Bn 28.47 Bn - -
7 Smith & Nephew 26.04 Bn 23.43 Bn - -
8 Sprott Physical Gold Trust 13.95 Bn 13.82 Bn - -
9 Magnum Ice Cream 11.80 Bn 10.44 Bn - -
10 Helus Pharma 373.09 Mn -229.42 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 -9.77 Mn
Dec 31, 2020 -8.73 Mn
Sep 30, 2020 -1.92 Mn
Jun 30, 2020 -3.04 Mn
API Access

Helus Pharma Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=HELP&period=max&api_key=YOUR_API_KEY